Tommy G. Thompson

Tommy G. Thompson, listed as board member, has filed trades across 6 companies (mainly through SEC (Form 4)), most often in UNITED THERAPEUTICS Corp, TherapeuticsMD, Inc. and Centene Corp. The record holds 48 filings, for trades running from 31 December 2015 to 26 March 2026.

Both buying and selling appear: 7 purchases worth €457k, against 1 sale. The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 6 share grants and 34 option exercises.

Half of the purchases are above €12k and half below. 3 out of 7 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 26 March 2026, the filings show an option exercise worth €176k in UNITED THERAPEUTICS Corp. The most recent open-market purchase was published on 29 December 2025, 293 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.